Skip to content
lifestyle.longislandreport.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Alector, Inc.
Alector to Participate in Upcoming Healthcare Conferences
September 3, 2026
Alector Reports Second Quarter 2026 Financial Results and Provides Business Update
August 6, 2026
Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer’s Disease Following Interim Futility Analysis
April 29, 2026